| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 51 |
| 1 | TADALAFIL | 32 |
| 2 | LENALIDOMIDE | 27 |
| 3 | ADALIMUMAB | 24 |
| 4 | DEXAMETHASONE | 23 |
| 5 | DEXAMETHASONE 1.5 MG | 23 |
| 6 | FUROSEMIDE | 23 |
| 7 | OMEPRAZOLE MAGNESIUM | 19 |
| 8 | ASPIRIN | 18 |
| 9 | ASPIRIN 325 MG | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SELENIUM | 8 | 0.0019 |
| 1 | DHEA (DEHYDROEPIANDROSTERONE) | 3 | 0.0016 |
| 2 | BARICITINIB | 3 | 0.0010 |
| 3 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 2 | 0.0008 |
| 4 | CARMUSTINE | 4 | 0.0008 |
| 5 | ACITRETIN | 4 | 0.0008 |
| 6 | PSYLLIUM HUSK | 1 | 0.0007 |
| 7 | GOLIMUMAB | 8 | 0.0006 |
| 8 | BENDAMUSTINE HCL | 9 | 0.0006 |
| 9 | VANDETANIB | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 48 |
| 1 | Corticosteroid [EPC] | 41 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 33 |
| 3 | Thalidomide Analog [EPC] | 30 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 26 |
| 5 | Loop Diuretic [EPC] | 25 |
| 6 | Interleukin-23 Antagonist [EPC] | 21 |
| 7 | Kinase Inhibitor [EPC] | 19 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 9 | Proton Pump Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Thymic Stromal Lymphopoietin Blocker [EPC] | 2 | 0.0003 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 33 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 5 | Interleukin-23 Antagonist [EPC] | 21 | 0.0002 |
| 6 | Androgen [EPC] | 5 | 0.0002 |
| 7 | Prostaglandin Analog [EPC] | 15 | 0.0002 |
| 8 | Interleukin-12 Antagonist [EPC] | 14 | 0.0001 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |